负载RGD衍生品的设计,合成和分析
Bonaventure Mujyambere1, Subasri Mohanakrishnan1, Shoufia Jabeen Mubarak2
1Department of Biochemistry, Bharathiar University, Coimbatore, Tamilnadu, India.
Bioinformation
|November 6, 2023
概括
与负电荷的N-Biotin-RGD相比,带有正电荷的C-生物-RGD对MDA-MB-231细胞表现出更高的细胞毒性,这是由与癌细胞表面的静电相互作用驱动的.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 药物运输 药物运输 药物运输
背景情况:
- 癌细胞的细胞表面电荷,特别是MDA-MB-231,主要是负的,这是由于超化和华堡效应.
- 了解和操纵静电相互作用对于向药物输送和癌症治疗至关重要.
研究的目的:
- 设计,合成和表征充电生物化RGD衍生物 (N-生物-RGD和C-生物-RGD).
- 研究这些衍生物对MDA-MB-231细胞的结合亲和和和细胞毒性作用,重点研究静电相互作用的作用.
主要方法:
- 合成和表征N-生物-RGD (负电荷) 和C-生物-RGD (正电荷).
- 对接分析以预测相互作用.
- 对固定在甲素 (中性) 和活细胞 (负电荷) MDA-MB-231细胞的结合亲和力的评估.
- 对活细胞MDA-MB-231的细胞毒性影响的评估.
主要成果:
- 与C-生物素-RGD相比,N-生物素-RGD对与甲胺固定的MDA-MB-231细胞具有更高的结合亲和力.
- 在活的MDA-MB-231细胞上,C-生物素-RGD显示出比N-生物素-RGD更高的细胞毒性作用.
- 细胞毒性与静电相互作用直接相关:C-生物-RGD的吸引导致更高的疗效,而N-生物-RGD的排斥导致更低的疗效.
结论:
- MDA-MB-231细胞的表面电荷显著影响生物化RGD衍生物的细胞毒性活性.
- 由于有利的静电相互作用,正电荷的C-生物-RGD比负电荷的N-生物-RGD对MDA-MB-231细胞更有效的细胞毒剂.
相关概念视频
Electrogravimetric Analysis: Overview
Electrogravimetric analysis measures the weight of an analyte deposited electrolytically onto a suitable working electrode. This method involves applying a potential to a pre-weighed electrode submerged in a solution, which results in the desired substance being deposited through reduction at the cathode or oxidation at the anode. The electrode's weight is recorded after deposition, and the difference in weight gives the analyte's weight in the solution.
To test the completeness of the...
To test the completeness of the...
The Electrical Double Layer
In the region where two bulk phases meet, an intricate electric charge distribution arises due to charge transfer, ion adsorption, molecular orientation, and charge distortion. This complex distribution is commonly referred to as the electrical double layer.When a solid electrode interfaces with ions in an electrolyte solution, the speed of electron transfer dictates the rates of oxidation and reduction. The electrode acquires a charge through the escape of atoms into the solution as cations or...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...


